MEDICAMENTE ANTINEOPLAZICE SI IMUNOMODULATOARE
TED · 717800-2026Contract noticeCloses in 31 days · 2026-11-16
Value
Estimated€91,040,669 · 485,337,806.13 RON
Awarded—
Who already wins at this buyer
Firms with recorded awards from SPITALUL MUNICIPAL PLOIESTI in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| TUNIC PROD S.R.L. | GLOBAL MEDICAL SOLUTIONS SRL | 1 | €178,210 | 2026-09-23 |
| ROCHE ROMANIA | 1 | €10,188 | 2026-06-05 |
| ALLIANCE HEALTHCARE ROMÂNIA SRL | FRESENIUS KABI ROMANIA SRL | DR.MAX | FARMEXIM S.A. | 1 | — | 2026-05-27 |
| DR.MAX | FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. | Pharma | FARMEXIM S.A. | ALLIANCE HEALTHCARE ROMANIA | 1 | — | 2026-10-07 |
Full buyer profile: what SPITALUL MUNICIPAL PLOIESTI buys and who wins it →
CPV codes
33652000 Medical equipment & pharmaceuticalsDescription
ACORD CADRU MEDICAMENTE ANTINEOPLAZICE SI IMUNOMODULATOARE conform caietului de sarcini
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-16 | MEDICAMENTE SIMPTOMATICE SI DE UZ SPITALICESC | SPITALUL MUNICIPAL PLOIESTI RO | 95% |
| 2026-05-27 | ACORD-CADRU MEDICAMENTE PENTRU SANGE SI PENTRU ORGANELE HEMATOPOIETICE, ANTIINFECTIOASE PENTRU UZ SISTEMIC, VACCINURI, ANTINEOPLAZICE SI IMUNOMODULATOARE | SPITALUL MUNICIPAL PLOIESTI RO | 93% |
| 2026-06-19 | ACHIZITIE MEDICAMENTE ANTINEOPLAZICE SI IMUNOMODULATOARE | SPITALUL DE PSIHIATRIE TITAN DR.CONSTANTIN GORGOS RO | 92% |
| 2026-07-28 | Medicamente uz uman pentru Programele Nationale de Sanatate | Spitalul Judetean de Urgenta Slobozia RO | 92% |
| 2026-10-07 | ACORD CADRU MEDICAMENTE PENTRU SANGE SI PENTRU ORGANELE HEMATOPOIETICE, ANTIINFECTIOASE GENERALE PENTRU UZ SISTEMIC, VACCINURI, ANTINEOPLAZICE SI IMUNOMODULATOARE PERIOADA 2026-2028 | SPITALUL MUNICIPAL PLOIESTI RO | 92% |
| 2026-05-20 | ACORD CADRU SOLUTII MEDICAMENTOASE SI ANTIINFECTIOASE GENERALE | SPITALUL CLINIC CAI FERATE IASI RO | 91% |